Scientific Industries Inc (SCND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 226 | 76 | -62 | N/A | -4 |
| Depreciation Amortization | 132 | 89 | 44 | N/A | 142 |
| Income taxes - deferred | 16 | 10 | 5 | N/A | 2 |
| Accounts receivable | -108 | -319 | -16 | N/A | 51 |
| Accounts payable and accrued liabilities | 25 | 28 | 64 | N/A | 24 |
| Other Working Capital | -61 | -187 | 29 | N/A | -64 |
| Other Operating Activity | 98 | 303 | -45 | 0 | -69 |
| Operating Cash Flow | $329 | $-1 | $20 | $N/A | $81 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -25 | -17 | N/A | -66 |
| Purchase Of Investment | 1 | 7 | -2 | N/A | -8 |
| Purchase Sale Intangibles | -2 | -2 | -2 | N/A | -265 |
| Other Investing Activity | -2 | -2 | -2 | 0 | -265 |
| Investing Cash Flow | $-30 | $-20 | $-22 | $N/A | $-339 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 60 |
| Debt Repayment | -57 | -38 | -19 | N/A | -91 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 10 |
| Dividend Paid | -40 | -40 | N/A | N/A | -60 |
| Other Financing Activity | -26 | 0 | 0 | 0 | -16 |
| Financing Cash Flow | $-123 | $-78 | $-19 | $N/A | $-97 |
| Beginning Cash Position | 769 | 769 | 769 | N/A | 908 |
| End Cash Position | 946 | 670 | 749 | N/A | 552 |
| Net Cash Flow | $177 | $-99 | $-21 | $N/A | $-356 |
| Free Cash Flow | |||||
| Operating Cash Flow | 329 | -1 | 20 | N/A | 81 |
| Capital Expenditure | -28 | -25 | -17 | N/A | -66 |
| Free Cash Flow | 301 | -26 | 2 | 0 | 15 |